Catherine Stehman Breen

Title: The Innovations of Catherine Stehman Breen

Introduction

Catherine Stehman Breen is a notable inventor based in York, ME (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of knee and hip pain. Her work focuses on developing effective solutions for patients who are non-responsive or intolerant to standard analgesic therapies.

Latest Patents

Catherine holds 1 patent for a pharmaceutical composition aimed at providing safe and effective treatment for knee and/or hip pain. This patent discloses a method for treating patients who do not respond well to conventional analgesics. Additionally, it outlines a pharmaceutical composition that reduces the risk of developing arthropathy in subjects receiving anti-NGF antibodies for knee and/or hip pain treatment. The patent also includes methods for monitoring the safety of such treatments, particularly for patients with osteoarthritis of the knee and/or hip, using the anti-NGF antibody fasinumab.

Career Highlights

Catherine is currently associated with Regeneron Pharmaceuticals, Inc., where she continues to innovate in the pharmaceutical sector. Her work is pivotal in advancing treatment options for patients suffering from chronic pain conditions.

Collaborations

Catherine has collaborated with esteemed colleagues such as Gregory P Geba and Paula Dakin, contributing to a dynamic research environment that fosters innovation and development in pharmaceutical therapies.

Conclusion

Catherine Stehman Breen's contributions to the field of pharmaceuticals exemplify her commitment to improving patient care through innovative treatments. Her work not only addresses significant medical needs but also showcases the importance of collaboration in advancing healthcare solutions.